Jefferies Downgrades Pacira Pharmaceuticals (PCRX) to Hold

October 8, 2026 12:37 PM EDT Send to a Friend
Jefferies analyst Glen Santangelo downgraded Pacira Pharmaceuticals (NASDAQ: PCRX) from Buy to Hold with a price target of $36.00.The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login